Anti-HIV immunogens and methods for inducing an immune response
US8338582B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 5, 2008 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Mar 9, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention refers to new epitopes recognized by CD4+ T-lymphocytes. In addition, the present invention refers to the uses of such epitopes and their combinations, particularly in the treatment or prevention of disorders caused by the HIV-1 virus.The present invention also refers to a composition comprising said epitopes and the uses of said composition, particularly in the treatment or prevention of disorders caused by the HIV-1 virus.The present invention also refers to anti-HIV-1 prophylactic vaccines and therapeutic vaccines.Furthermore, the present invention refers to a method for the identification of epitopes and methods for treating or preventing an infection caused by the HIV-1 virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.